AlphaFold 3, a new AI model developed by Isomorphic Labs and Google DeepMind has been introduced in a paper published in Nature. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, it will help…
Isomorphic Labs announces strategic collaborations with two of the world’s leading pharmaceutical companies, Eli Lilly and Company and Novartis. Both collaborations are multi-target, focused on small molecules, and include a combination of upfront and milestone payments. These partnerships have the…
Merck Group today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integration. It combines generative AI, machine learning and…
The University of Tsukuba and Astellas Pharma announced that they have signed a letter of confirmation regarding a strategic partnership to accelerate the digitalization of the drug discovery research field, as well as the development of the life science ecosystem…
Bagsværd, Denmark and Boston, Massachusetts, US, 25 September 2023 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation…